Skip to main content
. 2015 May;52(5):622–633. doi: 10.1165/rcmb.2014-0059OC

Figure 5.

Figure 5.

Severe rejection pathology and airway obliteration in lung allografts from T-bet−/− recipients is resistant to anti-CD154. (A, B) H&E-stained sections (original magnification: ×4, ×10) of lung allografts from WT and T-bet−/− recipients treated with anti-CD154. (C) H&E-stained sections (original magnification: ×20) of lung allografts from T-bet−/− recipients treated with anti-CD154 demonstrating a range of airway pathology. (D) Trichrome-stained section (original magnification: ×10, ×20) of lung allograft from T-bet−/− recipient treated with anti-CD154.